Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Wolf speed -- Ignore unavailable to you. Want to Upgrade?

To: Ron who wrote (4144)	10/26/2000 11:05:29 AM
From: MARK BARGER	Read Replies (1) \| Respond to of 10713

Just a quick question out of the blue. Does anyone understand the current craze going on with many of the biotech companies these days? Little revenue, no earnings on most of them, but promises of possibly billion dollar markets. Many of these biotechs have been rewarded with muiltibillion dollar market caps on promise alone. Many of these companies won't be profitable for years. Cree on the other hand, huge earnings, huge margins, even more huge promises of new products with even huger (is ther such a word?) multibillion markets. We are told that Mr. Market is rarely wrong, and never wrong in the long term. What are we to make of the fact of the incredible multiples in the DNA-based biotechs compared with the recent abuse piled on my poor Cree that has a great business NOW, and huge potential markets being addressed only months away. The more I compare Cree with other equities, the better it looks in every way, except the market can't sell Cree fast enough the past 6 months. Oh well, just idle thoughts today...